Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6395)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2013 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cholongitas E, Papatheodoridis GV. Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation. World J Gastroenterol 2013; 19(48): 9189-9197 [PMID: 24409047 DOI: 10.3748/wjg.v19.i48.9189] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v19/i48/9189.htm |
| Number | Citing Articles |
| 1 |
Soung Won Jeong, YoungRok Choi, Jin-Wook Kim. Management of viral hepatitis in liver transplant recipients. Clinical and Molecular Hepatology 2014; 20(4): 338 doi: 10.3350/cmh.2014.20.4.338
|
| 2 |
Masatoshi Ishigami, Yasuhiro Ogura, Yoshiki Hirooka, Hidemi Goto. Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation. World Journal of Gastroenterology 2015; 21(36): 10290-10298 doi: 10.3748/wjg.v21.i36.10290
|
| 3 |
Renfei Lu, Jianguo Shao, Min Zhou, Hongping Zhang, Yueping Wu. Accurate Detection of Hepatitis B Virus G1896A Mutant by Developed Taqman‐ARMS Followed a Strict Control System. Journal of Clinical Laboratory Analysis 2016; 30(4): 315 doi: 10.1002/jcla.21857
|
| 4 |
Afroditi Orfanidou, George V. Papatheodoridis, Evangelos Cholongitas. Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts. Liver International 2021; 41(7): 1448 doi: 10.1111/liv.14860
|
| 5 |
Eva Hulstaert, Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe. Intramuscular hepatitis B immunoglobulins for reinfection control after liver transplantation: a cost-saving alternative. Journal of Comparative Effectiveness Research 2015; 4(3): 259 doi: 10.2217/cer.15.4
|
| 6 |
Stela Celaj, Josh Levitsky. Prevention and Management of HBV in Organ Transplantation. Current Hepatology Reports 2020; 19(3): 266 doi: 10.1007/s11901-020-00537-7
|
| 7 |
Hong-Shiue Chou, Chih-Hsien Cheng, Hao-Chien Hung, Jin-Chiao Lee, Yu-Chao Wang, Tsung-Han Wu, Chen-Fang Lee, Ting-Jung Wu, Kun-Ming Chan, Wei-Chen Lee. Significance of Hepatitis B Recurrence in Liver Transplantation Recipients. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/2489526
|
| 8 |
Arun P. Nair, Sreethish Sasi, Muna S. Al‐Maslamani, Prem Chandra, Samar A. Hashim, Sulieman Abu Jarir, Moutaz Derbala. Epidemiological characteristics of de novo hepatitis B infection in liver transplant recipients—An experience from a tertiary care centre in Qatar. Transplant Infectious Disease 2020; 22(6) doi: 10.1111/tid.13444
|
| 9 |
Ranjit Chauhan, Shilpa Lingala, Chiranjeevi Gadiparthi, Nivedita Lahiri, Smruti R Mohanty, Jian Wu, Tomasz I Michalak, Sanjaya K Satapathy. Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management. World Journal of Hepatology 2018; 10(3): 352-370 doi: 10.4254/wjh.v10.i3.352
|
| 10 |
Evangelos Cholongitas, Konstantinos Tziomalos, Chrysoula Pipili. Management of patients with hepatitis B in special populations. World Journal of Gastroenterology 2015; 21(6): 1738-1748 doi: 10.3748/wjg.v21.i6.1738
|
| 11 |
I. Fernández, C. Loinaz, O. Hernández, M. Abradelo, A. Manrique, J. Calvo, M. Manzano, A. García, F. Cambra, G. Castellano, C. Jiménez. Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients. Transplant Infectious Disease 2015; 17(5): 695 doi: 10.1111/tid.12434
|
| 12 |
Zhuo-Lun Song, Yu-Jun Cui, Wei-Ping Zheng, Da-Hong Teng, Hong Zheng. Application of nucleoside analogues to liver transplant recipients with hepatitis B. World Journal of Gastroenterology 2015; 21(42): 12091-12100 doi: 10.3748/wjg.v21.i42.12091
|
| 13 |
Florian A. Lempp, Stephan Urban. Inhibitors of Hepatitis B Virus Attachment and Entry. Intervirology 2014; 57(3-4): 151 doi: 10.1159/000360948
|
| 14 |
Sahar Janfeshan, Ramin Yaghobi, Akram Eidi, Mohammad Hossein Karimi, Bita Geramizadeh, Seyed Ali Malekhosseini, Farshid Kafilzadeh. Study the Cross-talk Between Hepatitis B Virus Infection and Interferon Regulatory Factors in Liver Transplant Patients. Hepatitis Monthly 2017; 17(11) doi: 10.5812/hepatmon.12426
|
| 15 |
E. Cholongitas, T. Vasiliadis, I. Goulis, I. Fouzas, N. Antoniadis, V. Papanikolaou, E. Akriviadis. Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease. Journal of Viral Hepatitis 2015; 22(7): 574 doi: 10.1111/jvh.12362
|
| 16 |
Junichi Togashi, Nobuhisa Akamatsu, Yasuhiko Sugawara, Junichi Kaneko, Sumihito Tamura, Tomohiro Tanaka, Junichi Arita, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Norihiro Kokudo. One‐year extended, monthly vaccination prophylaxis combined with hepatitis B immune globulin for hepatitis B after liver transplantation. Hepatology Research 2016; 46(3) doi: 10.1111/hepr.12526
|
| 17 |
Evangelos Cholongitas, Ioannis Goulis, Nikolaos Antoniadis, Ioannis Fouzas, George Imvrios, Vasilios Papanikolaou, Evangelos Akriviadis. New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence. Transplant International 2014; 27(10): 1022 doi: 10.1111/tri.12370
|
| 18 |
Oscar Mitchell, Arif M. Cosar, Mohammad U. Malik, Ahmet Gurakar. Late liver function test abnormalities post-adult liver transplantation: a review of the etiology, investigation, and management. Hepatology International 2016; 10(1): 106 doi: 10.1007/s12072-015-9685-2
|
| 19 |
Yuan-Qing Zhang, Jin-Sheng Guo. Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(13): 3860-3866 doi: 10.3748/wjg.v21.i13.3860
|
| 20 |
Abhinav Vasudevan, Zaid S Ardalan, Navera Ahmed, Ross Apostolov, Paul J Gow, Adam G Testro, Ed J Gane, Peter W Angus. Long‐term safety and efficacy of tenofovir disoproxil fumarate substitution for hepatitis B immunoglobulin following liver transplantation. JGH Open 2018; 2(6): 288 doi: 10.1002/jgh3.12086
|
| 21 |
Haiyong Jia, Diwakar Rai, Peng Zhan, Xuwang Chen, Xuemei Jiang, Xinyong Liu. Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview. Future Medicinal Chemistry 2015; 7(5): 587 doi: 10.4155/fmc.15.19
|
| 22 |
Arno Kornberg. Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation. World Journal of Hepatology 2015; 7(11): 1494-1508 doi: 10.4254/wjh.v7.i11.1494
|